Clinical trials: Siderosis
Superficial Siderosis
Therapeutic Antioxidant Supplementation
A remotely administered study, non-randomized, non-blinded, controlled parallel assignment phase 2 trial to determine if oral inosine or inositol hexaphosphate will provide an effective long-term therapy to combat or slow neural…
- Trial name
- TAS-SS21 (NCT04890808)
- Testing
- Inosine, IP6
- Volunteers
- 50 people
- Sponsor
- Superficial Siderosis Research Alliance Inc.